Cargando…

Neuroprotective Effects of Casein-Derived Peptide Met-Lys-Pro (MKP) in a Hypertensive Model

We have previously reported that casein hydrolysate, CH-3, from bovine milk and casein-derived tripeptide Met-Lys-Pro (MKP) has ACE inhibitory activity and reduces blood pressure. In this study, we investigated the therapeutic effects of MKP in a hypertensive rat model (7-week-old male SHRSP/Izm rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tada, Asuka Matsuzaki, Hamezah, Hamizah Shahirah, Yanagisawa, Daijiro, Morikawa, Shigehiro, Tooyama, Ikuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457086/
https://www.ncbi.nlm.nih.gov/pubmed/32922259
http://dx.doi.org/10.3389/fnins.2020.00845
_version_ 1783575931475984384
author Tada, Asuka Matsuzaki
Hamezah, Hamizah Shahirah
Yanagisawa, Daijiro
Morikawa, Shigehiro
Tooyama, Ikuo
author_facet Tada, Asuka Matsuzaki
Hamezah, Hamizah Shahirah
Yanagisawa, Daijiro
Morikawa, Shigehiro
Tooyama, Ikuo
author_sort Tada, Asuka Matsuzaki
collection PubMed
description We have previously reported that casein hydrolysate, CH-3, from bovine milk and casein-derived tripeptide Met-Lys-Pro (MKP) has ACE inhibitory activity and reduces blood pressure. In this study, we investigated the therapeutic effects of MKP in a hypertensive rat model (7-week-old male SHRSP/Izm rats). For long term evaluation, rats were fed either a diet containing CH-3 or normal diet. The survival rate of SHRSP rats was significantly improved by intake of CH-3 for 181 days. For short term evaluation, rats were orally administered synthetic tripeptide MKP or distilled water for 4 weeks. MRI study demonstrated that hemorrhagic lesions were observed in two of five rats in the control group, while no hemorrhagic lesions were observed in the MKP group. Volumetric analysis using MRI revealed that MKP administration inhibited atrophy of diencephalic regions. Histological examinations revealed that hemorrhage areas and astrogliosis in the hippocampus and cerebral cortex were lower in the MKP group than in the control group. Gene expression analysis indicated that MKP administration reduced expression of genes related to cerebral circulation insufficiency such as immune responses (Cd74 and Prkcd), response to hypoxia (Ddit4, Apold1, and Prkcd), reactive oxygen species metabolic process (Ddit4 and Pdk4), and apoptotic process (Ddit4, Prkcd, and Sgk1), suggesting that MKP administration prevented cerebral ischemia associated with hypertension. In addition, some genes encoding responses to hormone stimulus (Fos, Dusp1, and Sik1) were also downregulated. Serum aldosterone and corticosterone levels were also significantly decreased following MKP administration. The present study indicates that MKP shows neuroprotective effects in SHRSP rats by regulating cerebral circulation insufficiency and corticoid levels. MKP administration may therefore be a potential therapeutic strategy for hypertensive brain diseases such as cerebrovascular disease.
format Online
Article
Text
id pubmed-7457086
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74570862020-09-11 Neuroprotective Effects of Casein-Derived Peptide Met-Lys-Pro (MKP) in a Hypertensive Model Tada, Asuka Matsuzaki Hamezah, Hamizah Shahirah Yanagisawa, Daijiro Morikawa, Shigehiro Tooyama, Ikuo Front Neurosci Neuroscience We have previously reported that casein hydrolysate, CH-3, from bovine milk and casein-derived tripeptide Met-Lys-Pro (MKP) has ACE inhibitory activity and reduces blood pressure. In this study, we investigated the therapeutic effects of MKP in a hypertensive rat model (7-week-old male SHRSP/Izm rats). For long term evaluation, rats were fed either a diet containing CH-3 or normal diet. The survival rate of SHRSP rats was significantly improved by intake of CH-3 for 181 days. For short term evaluation, rats were orally administered synthetic tripeptide MKP or distilled water for 4 weeks. MRI study demonstrated that hemorrhagic lesions were observed in two of five rats in the control group, while no hemorrhagic lesions were observed in the MKP group. Volumetric analysis using MRI revealed that MKP administration inhibited atrophy of diencephalic regions. Histological examinations revealed that hemorrhage areas and astrogliosis in the hippocampus and cerebral cortex were lower in the MKP group than in the control group. Gene expression analysis indicated that MKP administration reduced expression of genes related to cerebral circulation insufficiency such as immune responses (Cd74 and Prkcd), response to hypoxia (Ddit4, Apold1, and Prkcd), reactive oxygen species metabolic process (Ddit4 and Pdk4), and apoptotic process (Ddit4, Prkcd, and Sgk1), suggesting that MKP administration prevented cerebral ischemia associated with hypertension. In addition, some genes encoding responses to hormone stimulus (Fos, Dusp1, and Sik1) were also downregulated. Serum aldosterone and corticosterone levels were also significantly decreased following MKP administration. The present study indicates that MKP shows neuroprotective effects in SHRSP rats by regulating cerebral circulation insufficiency and corticoid levels. MKP administration may therefore be a potential therapeutic strategy for hypertensive brain diseases such as cerebrovascular disease. Frontiers Media S.A. 2020-08-14 /pmc/articles/PMC7457086/ /pubmed/32922259 http://dx.doi.org/10.3389/fnins.2020.00845 Text en Copyright © 2020 Tada, Hamezah, Yanagisawa, Morikawa and Tooyama. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Tada, Asuka Matsuzaki
Hamezah, Hamizah Shahirah
Yanagisawa, Daijiro
Morikawa, Shigehiro
Tooyama, Ikuo
Neuroprotective Effects of Casein-Derived Peptide Met-Lys-Pro (MKP) in a Hypertensive Model
title Neuroprotective Effects of Casein-Derived Peptide Met-Lys-Pro (MKP) in a Hypertensive Model
title_full Neuroprotective Effects of Casein-Derived Peptide Met-Lys-Pro (MKP) in a Hypertensive Model
title_fullStr Neuroprotective Effects of Casein-Derived Peptide Met-Lys-Pro (MKP) in a Hypertensive Model
title_full_unstemmed Neuroprotective Effects of Casein-Derived Peptide Met-Lys-Pro (MKP) in a Hypertensive Model
title_short Neuroprotective Effects of Casein-Derived Peptide Met-Lys-Pro (MKP) in a Hypertensive Model
title_sort neuroprotective effects of casein-derived peptide met-lys-pro (mkp) in a hypertensive model
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457086/
https://www.ncbi.nlm.nih.gov/pubmed/32922259
http://dx.doi.org/10.3389/fnins.2020.00845
work_keys_str_mv AT tadaasukamatsuzaki neuroprotectiveeffectsofcaseinderivedpeptidemetlyspromkpinahypertensivemodel
AT hamezahhamizahshahirah neuroprotectiveeffectsofcaseinderivedpeptidemetlyspromkpinahypertensivemodel
AT yanagisawadaijiro neuroprotectiveeffectsofcaseinderivedpeptidemetlyspromkpinahypertensivemodel
AT morikawashigehiro neuroprotectiveeffectsofcaseinderivedpeptidemetlyspromkpinahypertensivemodel
AT tooyamaikuo neuroprotectiveeffectsofcaseinderivedpeptidemetlyspromkpinahypertensivemodel